⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 16, 2024Open Access

Figure S5 from Proteasome Inhibition Reprograms Chromatin Landscape in Breast Cancer

H. Karimi Kinyamu Brian D. Bennett James M. Ward Trevor Archer

View Full Paper

Ask AI

Bookmark

Share

Abstract

Shows Effects of MG132 on accessibility of breast cancer specific super enhancers and predicted associated genes.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kinyamu et al. (2024) studied this question.

synapsesocial.com/papers/68e6ef2bb6db64358766a33b https://doi.org/10.1158/2767-9764.25611772.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S1 from Proteasome Inhibition Reprograms Chromatin Landscape in Breast Cancer2024
2Table S5 from Proteasome Inhibition Reprograms Chromatin Landscape in Breast Cancer2024
3Table S5 from Proteasome Inhibition Reprograms Chromatin Landscape in Breast Cancer2024
4Figure S6 from Proteasome Inhibition Reprograms Chromatin Landscape in Breast Cancer2024
5Figure S4 from Proteasome Inhibition Reprograms Chromatin Landscape in Breast Cancer2024

More related papers

Figure S3 from Proteasome Inhibition Reprograms Chromatin Landscape in Breast Cancer2024
Table S2 from Proteasome Inhibition Reprograms Chromatin Landscape in Breast Cancer2024
Table S2 from Proteasome Inhibition Reprograms Chromatin Landscape in Breast Cancer2024